SE0001151D0 - Method for producing a controlled-release composition - Google Patents

Method for producing a controlled-release composition

Info

Publication number
SE0001151D0
SE0001151D0 SE0001151A SE0001151A SE0001151D0 SE 0001151 D0 SE0001151 D0 SE 0001151D0 SE 0001151 A SE0001151 A SE 0001151A SE 0001151 A SE0001151 A SE 0001151A SE 0001151 D0 SE0001151 D0 SE 0001151D0
Authority
SE
Sweden
Prior art keywords
controlled
producing
pore
release composition
forming agent
Prior art date
Application number
SE0001151A
Other languages
English (en)
Inventor
John Kendrup
Peter Fyhr
Original Assignee
Amarin Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Dev Ab filed Critical Amarin Dev Ab
Priority to SE0001151A priority Critical patent/SE0001151D0/sv
Publication of SE0001151D0 publication Critical patent/SE0001151D0/sv
Priority to DE60106889T priority patent/DE60106889T2/de
Priority to JP2001572081A priority patent/JP4963767B2/ja
Priority to AT01914312T priority patent/ATE281156T1/de
Priority to EP01914312A priority patent/EP1267842B1/en
Priority to EP04025989A priority patent/EP1516616A1/en
Priority to AU2001239658A priority patent/AU2001239658A1/en
Priority to PCT/SE2001/000626 priority patent/WO2001074336A1/en
Priority to US09/819,813 priority patent/US6974591B2/en
Priority to US11/255,073 priority patent/US20060159755A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
SE0001151A 2000-03-31 2000-03-31 Method for producing a controlled-release composition SE0001151D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition
DE60106889T DE60106889T2 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
JP2001572081A JP4963767B2 (ja) 2000-03-31 2001-03-23 制御放出性製剤の製法
AT01914312T ATE281156T1 (de) 2000-03-31 2001-03-23 Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
EP01914312A EP1267842B1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release tablet using a pore forming agent in the coating
EP04025989A EP1516616A1 (en) 2000-03-31 2001-03-23 A controlled-release preparation having specific pore forming agents in the coating
AU2001239658A AU2001239658A1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release preparation
PCT/SE2001/000626 WO2001074336A1 (en) 2000-03-31 2001-03-23 Method for producing a controlled-release preparation
US09/819,813 US6974591B2 (en) 2000-03-31 2001-03-29 Method for producing a controlled-release preparation
US11/255,073 US20060159755A1 (en) 2000-03-31 2005-10-19 Method for producing a controlled release preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Publications (1)

Publication Number Publication Date
SE0001151D0 true SE0001151D0 (sv) 2000-03-31

Family

ID=20279094

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001151A SE0001151D0 (sv) 2000-03-31 2000-03-31 Method for producing a controlled-release composition

Country Status (8)

Country Link
US (2) US6974591B2 (sv)
EP (2) EP1516616A1 (sv)
JP (1) JP4963767B2 (sv)
AT (1) ATE281156T1 (sv)
AU (1) AU2001239658A1 (sv)
DE (1) DE60106889T2 (sv)
SE (1) SE0001151D0 (sv)
WO (1) WO2001074336A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551617B1 (en) * 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1539144B1 (en) * 2002-09-20 2014-12-24 Andrx Labs Llc Multistage formulation containing a biguanide and a thiazolidinedione derivative
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same
JP5095615B2 (ja) 2005-06-27 2012-12-12 バリアント・インターナショナル・（バルバドス）・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ ブプロピオン塩の放出調整製剤
ES2378573T3 (es) 2006-03-16 2012-04-16 Tris Pharma, Inc. Formulaciones de liberación modificada que contienen complejos de fármaco-resina de intercambio iónico
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
DE102006030860A1 (de) * 2006-07-04 2008-01-10 Universität Regensburg Oligomere von Isonitril-Metallkomplexen als Triplett-Emitter für OLED-Anwendungen
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
MX2011012315A (es) 2009-05-19 2011-12-16 Neuroderm Ltd Composiciones para la administracion continua de inhibidores de dopa descarboxilasa.
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
JP5902705B2 (ja) 2010-11-15 2016-04-13 ニューロダーム リミテッドＮｅｕｒｏｄｅｒｍ Ｌｔｄ Ｌ−ドーパ、ドーパデカルボキシラーゼ阻害剤、カテコール−ｏ−メチルトランスフェラーゼ阻害剤、およびそれらのための組成物の継続的投与
EP2481411A1 (en) * 2011-01-27 2012-08-01 Ratiopharm GmbH Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib
CA2875446A1 (en) 2012-06-05 2013-12-12 Neuroderm Ltd. Compositions comprising apomorphine and organic acids and uses thereof
PL2872121T3 (pl) 2012-07-12 2019-02-28 SpecGx LLC Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
WO2014028610A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
EP3116475B1 (en) 2014-03-13 2020-11-04 Neuroderm Ltd Dopa decarboxylase inhibitor compositions
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB587055I5 (sv) * 1956-05-24
US4557925A (en) 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
US4629619A (en) * 1984-09-05 1986-12-16 Ab Ferrosan Membrane-coated sustained-release tablets and method
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5376383A (en) 1988-11-21 1994-12-27 Merck & Co., Inc. Method for enhancing the lowering of plasma-cholesterol levels
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5324351A (en) * 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas

Also Published As

Publication number Publication date
US6974591B2 (en) 2005-12-13
JP2003528910A (ja) 2003-09-30
DE60106889T2 (de) 2006-03-23
ATE281156T1 (de) 2004-11-15
WO2001074336A1 (en) 2001-10-11
EP1267842B1 (en) 2004-11-03
EP1267842A1 (en) 2003-01-02
EP1516616A1 (en) 2005-03-23
AU2001239658A1 (en) 2001-10-15
JP4963767B2 (ja) 2012-06-27
US20010038853A1 (en) 2001-11-08
US20060159755A1 (en) 2006-07-20
DE60106889D1 (de) 2004-12-09

Similar Documents

Publication Publication Date Title
SE0001151D0 (sv) Method for producing a controlled-release composition
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
ATE342714T1 (de) Verfahren zur herstellung von oralen calcium zusammensetzungen
DE69331948D1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
DK0377518T3 (da) Farmaceutisk præparat med langvarig frigivelse
DE60034565D1 (de) Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
TNSN91067A1 (fr) Procede de preparation de compositions a liberation prolongee et compositions ainsi obtenues.
EP0377517A3 (en) Theophylline dosage form
ATE286387T1 (de) Clarithromycin enthaltende zubereitung mit verlängerter freisetzung
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
EE200100161A (et) Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid
ATE327737T1 (de) Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen
BR9709858A (pt) Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto
ATE288271T1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
ATE214598T1 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
EP1258254A4 (en) COMPOSITIONS FOR DELAYED DELIVERY OF PHYSIOLOGICALLY ACTIVE COMPOUNDS THAT ARE LOW WATER-SOLUBLE, METHOD FOR THE PRODUCTION AND USE THEREOF
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
GB2424185A (en) Cough mixture comprising codeine linctus and guaifenesin
DE50105577D1 (de) Ribavirin-granulat zur herstellung von filmtabletten
JPS54126722A (en) Slow release antibiotic tablet
FI20030379A0 (sv) Ny farmaceutisk komposition
BRPI0109640B8 (pt) forma farmacêutica multiparticulada adequada para liberação uniforme de um ingrediente farmacêutico ativo no intestino delgado e no intestino grosso, seu processo de produção e seu uso
RU93049678A (ru) Устойчивый водорастворимый ветеринарный препарат и способ его получения